← Back to Clinical Trials
Recruiting NCT07150702

NCT07150702 Effects of Close Follow-up on Patients With Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07150702
Status Recruiting
Phase
Sponsor Istanbul Training and Research Hospital
Condition Low Back Pain
Study Type INTERVENTIONAL
Enrollment 74 participants
Start Date 2025-09-01
Primary Completion 2025-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Conventional physical therapy programClose follow-up by a physician

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 74 participants in total. It began in 2025-09-01 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will include patients aged 18-65 with subacute or chronic mechanical low back pain who apply to the Physical Medicine and Rehabilitation Clinic. The age, gender, body mass index, duration of low back pain, smoking status, and educational status of the patients included in the study will be recorded. Patients will be randomized into two groups: the study group and the control group. First, the psychosocial risk status of patients in both groups will be determined using the STarT Back Screening Tool. Then, patients in the control group will undergo a conventional physical therapy program that includes hot packs, transcutaneous electrical nerve stimulation, ultrasound, and core stabilization exercises. Patients in the study group will undergo daily close follow-up physician-patient meetings during the sessions, in addition to the conventional physical therapy program applied to the control group. Clinical assessments will be performed using the Visual Analogue Scale (VAS), Tampa Scale of Kinesiophobia, Pain Catastrophizing Scale, Beck's Depression Scale, Roland-Morris Disability Questionnaire, and Leeds Assessment of Neuropathic Symptoms and Signs. Clinical evaluations will be conducted at baseline, on Day 5 post-treatment, and at 1 month post-treatment.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18-65 with subacute or chronic mechanical back pain and considered appropriate for a physical therapy program. Exclusion Criteria: * Patients describing inflammatory back pain * Spondyloarthropathies and other rheumatological diseases * History of spinal surgery * Patients with sensory disturbances and psychiatric diagnoses * Fibromyalgia * Patients with malignancies * Patients with active infectious findings * Patients with a history of radiotherapy

Frequently Asked Questions

Who can join the NCT07150702 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07150702 currently recruiting?

Yes, NCT07150702 is actively recruiting participants. Visit ClinicalTrials.gov or contact Istanbul Training and Research Hospital to inquire about joining.

Where is the NCT07150702 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07150702 clinical trial?

NCT07150702 is sponsored by Istanbul Training and Research Hospital. The trial plans to enroll 74 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology